Oxford Nanopore TechnologiesOXFYY -11.92%50 PS Ratio is 5.18 as of Jul. 01, 2026, which is 35% below its 10-year median of 8.02. GuruFocus rates OXFYY with a GF Score™ of 50/100 and a GF Value™ of $10.40 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 934 Biotechnology companies, Oxford Nanopore Technologies ranks better than 63.92% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Oxford Nanopore Technologies's share price is $6.50.
Oxford Nanopore Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $1.25. Hence, Oxford Nanopore Technologies's PS Ratio for today is 5.18.
The historical rank and industry rank for Oxford Nanopore Technologies's PS Ratio or its related term are showing as below:
OXFYY'
s PS Ratio Range Over the Past 10 Years
Min: 4.55 Med: 8.02 Max: 49.65
Current: 5.35
During the past 8 years, Oxford Nanopore Technologies's highest PS Ratio was 49.65. The lowest was 4.55. And the median was 8.02.
OXFYY's PS Ratio is ranked better than 63.92% of 934
companies
in the Biotechnology industry
Industry Median: 9.515
vs OXFYY: 5.35
During the past 8 years, Oxford Nanopore Technologies's highest 3-Year average Revenue per Share Growth Rate was 64.60% per year. The lowest was -1.10% per year. And the median was 12.40% per year.
Back to Basics: PS Ratio
Oxford Nanopore Technologies (OTCPK:OXFYY) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Oxford Nanopore Technologies PS Ratio Related Terms
Oxford Nanopore Technologies PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Oxford Nanopore Technologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oxford Nanopore Technologies PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's PS Ratio distribution charts can be found below:
* The bar in red indicates where Oxford Nanopore Technologies's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Oxford Nanopore Technologies's Share Price of today is $6.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oxford Nanopore Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $1.25.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Oxford Nanopore Technologies (OXFYY) has a PS Ratio of 5.18 as of Jul. 01, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Oxford Nanopore Technologies and its competitors. This is 35% below median its historical median of 8.02. Over the past decade, Oxford Nanopore Technologies' PS Ratio has ranged from 4.55 to 49.65. According to the industry distribution chart, Oxford Nanopore Technologies ranks #337 out of 934 companies in the Biotechnology industry, placing it in the top 36.1%.
Is Oxford Nanopore Technologies' PS Ratio too high?
Oxford Nanopore Technologies' current PS Ratio of 5.18 is 35% below median its 10-year median of 8.02. Over the past 10 years, this metric has ranged from a low of 4.55 to a high of 49.65. The Biotechnology industry median PS Ratio is 9.52. Oxford Nanopore Technologies' value of 5.18 is 45.6% below this industry median. Based on the distribution chart, Oxford Nanopore Technologies ranks #337 out of 934 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Oxford Nanopore Technologies has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Oxford Nanopore Technologies' PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Oxford Nanopore Technologies ranks #337 out of 934 companies for PS Ratio. This puts Oxford Nanopore Technologies in the upper half of its industry. The industry median PS Ratio is 9.52. Oxford Nanopore Technologies' value of 5.18 is 45.6% below this benchmark. Historically, Oxford Nanopore Technologies' own PS Ratio has ranged from 4.55 to 49.65 over the past decade. While the company's 10-year median is 8.02 vs. the industry median of 9.52, Oxford Nanopore Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.52, based on 934 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oxford Nanopore Technologies's current PS Ratio of 5.18 is 45.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Oxford Nanopore Technologies and its competitors. For the Biotechnology industry, the median PS Ratio is 9.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oxford Nanopore Technologies's current PS Ratio is 5.18, which is 35% below median its own 10-year median of 8.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford Nanopore Technologies stock overvalued right now?
Based on GuruFocus' analysis, Oxford Nanopore Technologies (OXFYY) is currently considered Significantly Undervalued. The stock's GF Value™ is $10.40, compared to a current price of $6.50 — trading 37.5% below its estimated fair value. The current PS Ratio is 5.18, which is 35% below median its 10-year median of 8.02 and 45.6% below the Biotechnology industry median of 9.52. Oxford Nanopore Technologies' overall GF Score™ is 50/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Oxford Nanopore Technologies (OXFYY), the current PS Ratio is 5.18 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oxford Nanopore Technologies (OXFYY) Overvalued in 2026?
Based on GuruFocus' analysis, Oxford Nanopore Technologies stock appears to be undervalued.
The current stock price of $6.50 is trading 37.5% below its estimated GF Value™ of $10.40.
GuruFocus considers Oxford Nanopore Technologies to be Significantly Undervalued.
Key valuation signals for OXFYY:
PS Ratio: 5.18 (35% below median its 10-year median of 8.02)
GF Value™: $10.40 vs. price of $6.50 (37.5% below fair value)
Industry Position: 45.6% below the Biotechnology median (#337 of 934)
No single metric tells the full story. See the OXFYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oxford Nanopore Technologies PLC is involved in researching, developing, manufacturing and commercializing deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that provides rich data, is fast, accessible and easy to use, and which allows the real-time analysis of DNA or RNA. It has developed and brought to market a new generation molecular sensing platform based on nanopores. The first application is DNA/RNA sequencing and the platform is also being developed for the analysis of proteins and metabolites. It operates in single segment of providing products and services related to the sale and use of its nanopore-based sensing technology. Geographically its operations are spread across EMES, AMR, and APAC.
50GF Score
Get the complete analysis for OXFYY
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OXFYY has been successfully added to your 
